Barclays
CLOV icon

Barclays’s Clover Health Investments CLOV Stock Holding History

Barclays’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
67,658
-10,376
-13% -$35.2K ﹤0.01% 3393
2026
Q1 		$137K Sell
78,034
-559,245
-88% -$1.21M ﹤0.01% 3893
2025
Q4 		$1.5M Buy
637,279
+59,327
+10% +$162K ﹤0.01% 3139
2025
Q3 		$1.77M Sell
577,952
-222,722
-28% -$636K ﹤0.01% 2967
2025
Q2 		$2.23M Buy
800,674
+354,520
+79% +$1.17M ﹤0.01% 2760
2025
Q1 		$1.6M Sell
446,154
-15,538
-3% -$62.4K ﹤0.01% 2799
2024
Q4 		$1.45M Buy
461,692
+355,926
+337% +$1.27M ﹤0.01% 3122
2024
Q3 		$298K Buy
+105,766
New +$242K ﹤0.01% 4095
2024
Q2 		– Sell
-75,915
Closed -$60.3K – 4927
2024
Q1 		$60.3K Sell
75,915
-471,146
-86% -$429K ﹤0.01% 4576
2023
Q4 		$521K Buy
547,061
+481,828
+739% +$473K ﹤0.01% 3845
2023
Q3 		$70.5K Buy
65,233
+1,589
+2% +$1.89K ﹤0.01% 3720
2023
Q2 		$57.1K Sell
63,644
-172,612
-73% -$153K ﹤0.01% 3776
2023
Q1 		$200K Buy
236,256
+81,618
+53% +$89.3K ﹤0.01% 3795
2022
Q4 		$144K Buy
154,638
+87,349
+130% +$117K ﹤0.01% 4022
2022
Q3 		$115K Buy
67,289
+13,555
+25% +$35.5K ﹤0.01% 3481
2022
Q2 		$115K Buy
53,734
+51,694
+2,534% +$137K ﹤0.01% 3712
2022
Q1 		$7K Buy
+2,040
New +$5.92K ﹤0.01% 4652

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Barclays's CLOV Position: Q2 2026 in Review

Barclays reduced its Clover Health Investments (CLOV) stake by 13% in Q2 2026, selling an estimated $35.2K and leaving 67,658 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Barclays first reported a position in CLOV in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.23M in Q2 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Barclays held 67,658 shares of Clover Health Investments worth $355K as of Q2 2026.
  • Barclays sold 10,376 Clover Health Investments shares in Q2 2026, an estimated $35.2K.
  • Clover Health Investments made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3393 holding.
  • Barclays first reported a position in Clover Health Investments in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Clover Health Investments position peaked at $2.23M in Q2 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.